Smoking and Coronary Atherosclerosis: Disproportionate Impact on the Right Coronary Artery

Axel Dahlgren1, David Erlinge1, Ryo Torii2

  • 1Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

Insights

Smoking significantly accelerates coronary atherosclerosis plaque progression, particularly in the right coronary artery (RCA). This highlights the urgent need for smoking cessation programs to prevent cardiovascular disease.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Public Health

Background:

  • Smoking is a major risk factor for cardiovascular disease.
  • Understanding its long-term impact on coronary atherosclerosis at a detailed level is crucial for prevention and treatment strategies.

Purpose of the Study:

  • To investigate the long-term effects of smoking on coronary atherosclerosis progression at the segmental level.
  • To compare plaque progression patterns between current smokers, former smokers, and nonsmokers.

Main Methods:

  • Analysis of angiographic data from the Swedish Coronary Angiography and Angioplasty Registry (1989-2017).
  • Inclusion of patients with clinically indicated angiography and at least two coronary arteries without obstructive coronary artery disease.
  • Validation using data from the Western Denmark Heart Registry.
  • Primary outcome: segmental plaque progression, percutaneous coronary intervention, or coronary artery bypass grafting within 15 years.

Main Results:

  • A large cohort of 215,364 Swedish patients and 19,613 in the validation cohort were analyzed.
  • Plaque progression incidence rates per 1000 patient-years were higher in smokers (11.3) and former smokers (10.2) compared to nonsmokers (7.7).
  • Smokers showed a significantly higher risk of plaque progression in the right coronary artery (RCA) compared to the left anterior descending artery (LAD).
  • Smokers with ST-segment elevation myocardial infarction (STEMI) more frequently had RCA as the culprit artery compared to nonsmokers.

Conclusions:

  • Smoking is associated with distinct patterns of coronary plaque progression, with a notable increase in the RCA.
  • These findings underscore the importance of smoking prevention and cessation efforts.
  • Further research into RCA-specific mechanisms of plaque progression and myocardial infarction (MI) is warranted.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
374
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
923
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
470